# Multiple Signaling Axes (TNF-α/IL1β/IL8, TLR4/MYD88/NF-κB, and TGF-β1/ROS) Associated With Coronary Collateral Circulation of Coronary Chronic Total Occlusion in Geriatric Patients

**Authors:** Yongjuan Zhao, Hualan Zhou, Ying Chen, Dianxuan Guo

PMC · DOI: 10.1155/mi/3045323 · Mediators of Inflammation · 2025-11-15

## TL;DR

This study explores how certain inflammatory signaling pathways are linked to poor blood vessel formation in elderly patients with heart blockages.

## Contribution

The study identifies multiple signaling axes that may impair coronary collateral circulation in geriatric patients with chronic total occlusion.

## Key findings

- CCC Grade 2 patients showed decreased levels of TNF-α, IL1β, IL8, TLR4, MYD88, NF-κB, TGF-β1, and ROS compared to Grade 1 patients.
- Grade 1 patients had lower levels of these markers than Grade 0 patients, indicating a correlation between marker levels and CCC severity.
- The findings suggest that these signaling axes contribute to poor CCC formation in elderly CCTO patients.

## Abstract

The multiple signaling axes might be concerned with the poor coronary collateral circulation (CCC). This research aimed to investigate the relationship between the poor CCC and multiple signaling axes (tumor necrosis factor-α [TNF-α]/interleukin-1β [IL1β]/IL8 pro-inflammatory cytokine signaling axis, toll-like receptor 4/myeloid differentiation factor 88/nuclear factor kappa-B [TLR4/MYD88/NF-κB] immune-inflammatory signaling axis, and transforming growth factor-β1/reactive oxygen species [TGF-β1/ROS] oxidative stress-inflammatory signaling axis) in geriatric patients with coronary chronic total occlusion (CCTO). We simultaneously assessed the expressions of multiple signaling axis markers (TNF-α, IL1β, IL8, TLR4, MYD88, NF-κB, TGF-β1, and ROS) in geriatric patients with CCTO. The CCC was scored as follows: Grade 0 (without contrast filling), Grade 1 (filling of collateral vessels with no epicardial filling), Grade 2 (partial filling of epicardial arteries), and Grade 3 (fully filling of the epicardial arteries). The CCC Grade 2 group in patients with CCTO showed decreased TNF-α, IL1β, IL8, TLR4, MYD88, NF-κB, TGF-β1, and ROS compared with CCC Grade 1 group (p < 0.002), and the CCC Grade 1 group had lower levels of these markers than CCC Grade 0 group (p < 0.002). In conclusion, our findings may support the causative roles for the pro-inflammatory cytokine signaling axis (TNF-α/IL1β/IL8), immune-inflammatory signaling axis (TLR4/MYD88/NF-κB), and oxidative stress-inflammatory signaling axis (TGF-β1/ROS) in impairing CCC and poor formation of CCC in geriatric CCTO patients.

## Linked entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124], IL1B (interleukin 1 beta) [NCBI Gene 3553], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576], TLR4 (toll like receptor 4) [NCBI Gene 7099], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098]

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** inflammatory (MESH:D007249), CCTO (MESH:D054059)
- **Chemicals:** ROS (MESH:D017382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12640262/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12640262/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12640262/full.md

---
Source: https://tomesphere.com/paper/PMC12640262